Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
LENZ Therapeutics, Inc.
13G
LENZ · 52635N103
|
5.1% |
4/8/2026
Event 4/1/2026
|
|||
| Squarepoint Ops LLC | 5.1% | ||||
| Squarepoint Capital LLP | 5.1% | ||||
| Squarepoint Operations Private Limited | 5.1% | ||||
| Squarepoint (DIFC) Ltd | 5.1% | ||||
| Squarepoint Master Fund Limited | 5.1% | ||||
| Squarepoint Core Master Fund Limited | 0% | ||||
|
Cartesian Therapeutics, Inc.
13G
RNAC · 816212302
|
8.3% |
3/13/2026
Event 3/9/2026
|
|||
| Squarepoint Ops LLC | 8.3% | ||||
| Squarepoint Capital LLP | 8.3% | ||||
| Squarepoint Operations Private Limited | 8.3% | ||||
| Squarepoint (DIFC) Ltd | 8.3% | ||||
| Squarepoint Master Fund Limited | 8.2% | ||||
| Squarepoint Core Master Fund Limited | 0.1% | ||||